Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Single-center Pharmacokinetic Study of DARE-BV1 in Healthy Female Subjects

NCT05354050 is registered in ClinicalTrials.gov with Daré Bioscience, Inc. as lead sponsor.

NCT NCT05354050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05354050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Single-center Pharmacokinetic Study of DARE-BV1 in Healthy Female Subjects
Lead sponsor
Daré Bioscience, Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 3, 2020
Completion date
December 2, 2020
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis